ReviewPharmaceuticals (Basel, Switzerland)2025

The Anti-Inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology.

Majid Eslami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.